We are live on ! Find out more
HTHT

Hemenway Trust Hemenway Trust Portfolio holdings

AUM $1.24B
1-Year Est. Return 16.52%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+16.52%
3 Year Est. Return
+58.5%
5 Year Est. Return
+76.55%
10 Year Est. Return
+293.68%
AUM
$1.17B
AUM Growth
+$13.6M
Cap. Flow
-$10.1M
Cap. Flow %
-0.87%
Top 10 Hldgs %
42.37%
Holding
136
New
4
Increased
25
Reduced
76
Closed
7

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$10.2M
2
NVS icon
Novartis
NVS
+$7M
3
NVDA icon
NVIDIA
NVDA
+$3.26M
4
CVS icon
CVS Health
CVS
+$2.98M
5
ADI icon
Analog Devices
ADI
+$1.97M

Sector Composition

Rank Sector Weight
1 Technology 31.02%
2 Healthcare 19.46%
3 Industrials 13.07%
4 Consumer Discretionary 11.61%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$123B
$13.3M 1.14%
28,437
+12,919
+83% +$5.61M
CARR icon
27
Carrier Global
CARR
$53.9B
$12.9M 1.1%
203,815
+95,645
+88% +$5.87M
WM icon
28
Waste Management
WM
$89.7B
$11.3M 0.97%
52,906
-4,960
-9% -$1.03M
BALL icon
29
Ball Corp
BALL
$16.8B
$11.3M 0.97%
187,963
+87,207
+87% +$5.84M
NEE icon
30
NextEra Energy
NEE
$179B
$6.35M 0.54%
89,646
+4,641
+5% +$329K
UNP icon
31
Union Pacific
UNP
$176B
$5.96M 0.51%
26,353
-40
-0.2% -$9.38K
MKC icon
32
McCormick & Company Non-Voting
MKC
$14.1B
$5.81M 0.5%
+81,851
New +$5.96M
ABBV icon
33
AbbVie
ABBV
$435B
$5.09M 0.44%
29,668
-2,180
-7% -$361K
APTV icon
34
Aptiv
APTV
$9.76B
$4.27M 0.37%
60,653
+4,685
+8% +$360K
HON icon
35
Honeywell
HON
$78.6B
$4.17M 0.36%
20,721
-2,360
-10% -$449K
ADBE icon
36
Adobe
ADBE
$103B
$3.7M 0.32%
6,663
+632
+10% +$306K
NKE icon
37
Nike
NKE
$63B
$3.58M 0.31%
47,513
-110,191
-70% -$10.2M
NTAP icon
38
NetApp
NTAP
$36.6B
$3.38M 0.29%
26,250
-8,000
-23% -$898K
TMO icon
39
Thermo Fisher Scientific
TMO
$214B
$3.18M 0.27%
5,758
-214
-4% -$123K
WMT icon
40
Walmart Inc
WMT
$894B
$2.61M 0.22%
38,523
-3,708
-9% -$234K
JPM icon
41
JPMorgan Chase
JPM
$955B
$2.19M 0.19%
10,843
-141
-1% -$27.6K
NVS icon
42
Novartis
NVS
$294B
$2.13M 0.18%
19,980
-69,731
-78% -$7M
ECL icon
43
Ecolab
ECL
$80.3B
$2.11M 0.18%
8,860
+90
+1% +$20.8K
PEP icon
44
PepsiCo
PEP
$189B
$2.09M 0.18%
12,679
-648
-5% -$112K
APH icon
45
Amphenol
APH
$212B
$2.02M 0.17%
29,960
-2,548
-8% -$161K
XOM icon
46
ExxonMobil
XOM
$628B
$1.86M 0.16%
16,163
+166
+1% +$19.3K
CHD icon
47
Church & Dwight Co
CHD
$24.6B
$1.83M 0.16%
17,681
-3,130
-15% -$331K
NVO
48
Novo Nordisk
NVO
$197B
$1.63M 0.14%
11,388
CVS icon
49
CVS Health
CVS
$126B
$1.52M 0.13%
25,686
-47,604
-65% -$2.98M
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.4T
$1.49M 0.13%
8,148
+3
+0% +$510

Similar funds

Hemenway Trust Hemenway Trust's Q2 2024 Portfolio in Review

As of Q2 2024, Hemenway Trust Hemenway Trust held 136 positions worth $1.17B, up 1.2% from $1.15B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Hemenway Trust Hemenway Trust's Q2 2024 filing shows 4 new, 25 increased, 76 reduced and 7 closed positions. Its largest new stake was McCormick & Company Non-Voting: 81,851 shares worth $5.81M. The largest sale was Nike, an estimated $10.2M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Hemenway Trust Hemenway Trust's largest Q2 2024 buy was McCormick & Company Non-Voting: 81,851 shares worth $5.81M.
  • Hemenway Trust Hemenway Trust added most to Carrier Global in Q2 2024, an estimated $5.87M increase.
  • Hemenway Trust Hemenway Trust's biggest Q2 2024 reduction was Nike, cutting an estimated $10.2M.
  • Hemenway Trust Hemenway Trust fully exited Gilead Sciences in Q2 2024, selling an estimated $487K.
  • Hemenway Trust Hemenway Trust's ten largest holdings make up 42% of its $1.17B portfolio in Q2 2024.
  • Hemenway Trust Hemenway Trust opened 4 new positions and closed 7 in Q2 2024.
  • Hemenway Trust Hemenway Trust's portfolio value rose 1.2% quarter-over-quarter to $1.17B.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q2 2024, filed 5 Aug 2024.